Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Gitelman’s Syndrome

A milder clinical course with symptoms usually not apparent before age 5-10, and hypocalciuria with hypomagnesemia has been the clinical distinction between Gitelman s syndrome and true Bartter s... [Pg.537]

Example, Bartter s or Gitelman s syndrome, Cushing s syndrome, hyperaldosteronism (1° or 2°), and Liddle s syndrome... [Pg.180]

Calo, L. A., Pagnin, E., Davis, P. A., et al. (2004) Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter s/Gitelman s syndrome. A role in the control of vascular tone and implication for hypertension. J. Clin. Endocrinol. Metab. 89, 4153 157. [Pg.103]

Features include muscle weakness and cramps, paraesthesia, nausea, vomiting, constipation, abdominal pain, polyuria, polydipsia, depression, confusion and psychosis. Hypokalaemia may cause brady/tachyarrhythmias, hypotension, respiratory failure, ileus and altered mental state. It also increases the toxicity of cardiac glycosides. There are several associated disease states (e.g. diarrhoea, vomiting, renal tubular acidosis types I and II, hypomagnesaemia, Conn s syndrome, Cushing s disease, Gitelman s syndrome, villous adenoma, pyloric stenosis, intestinal fistulae). [Pg.864]

Kunchaparty S, Palcso M, Berkman J et al (1999) Defective processing and expression of thiazide-sensitive Na-Cl cotransporter as a cause of Gitelman s syndrome. Am J Physiol 277 F643-F649... [Pg.186]

Excess mineralocorticoid activity Hyperaldosteronism Cushing s syndrome Bartter s syndrome Gitelman s syndrome Excessive black licorice intake Profound potassium depletion Magnesium deficiency Liddle s syndrome Unclassified Alkali administration Milk-alkali syndrome... [Pg.994]

Colussi G, Rombola G, De Eerrari ME, et al. Correction of hypokalemia with antialdosterone therapy in Gitelman s syndrome. Am J Nephrol 1994 14 127-135. [Pg.1002]

SLC12 Electroneutral cation-Cl" cotransporter family 9 Gitelman s syndrome... [Pg.33]

Na or Ct binding to the Na -Ct symporter modifies thiazide-induced inhibition of the symporter, suggesting that the thiazide-binding site is shared or altered by both Na and Ct. The Na -Ct symporter (called ENCCl) is expressed predominantly in the kidney and is localized to the apical membrane of DCT epithelial cells its expression is regulated by aldosterone. Mutations in the Na -Ct symporter cause a familial hypokalemic alkalosis called Gitelman s syndrome. [Pg.488]

Hypermagnesuria is encountered in the case of metabolic and iatrogenic disorders, such as primary and secondary hyperaldosteronism (extracellular volume expansion), hypercalcemia (competition Ca/Mg at the thick ascending loop of Henle), hyperparathyroidism, and phosphate or potassium depletion. Hypermagnesuria may also result from tubulopathy, as the selective defect of the Mg tubular reabsorption (chromosome Hq23), Bartter s syndrome (thick ascending loop of Henle), or Gitelman s syndrome (distal convoluted tubule). [Pg.253]

Kamel, K. S., Oh, M. S. and Halperin, M. L. (2002). Bartter s, Gitelman s, and Gordon s syndromes. From physiology to molecular biology and back, yet still some unanswered questions. Nephron. 92(Suppl. 1), 18-27. [Pg.187]

Simon DB, Nelson-WiUiams C, Bia MJ, EUison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitleman HJ, Lifton RP. 1996. Gitelman s variant of Bartter s syndrome, inherited hypokalaemic alkalosis, is eaused... [Pg.382]


See other pages where Gitelman’s Syndrome is mentioned: [Pg.537]    [Pg.1493]    [Pg.181]    [Pg.537]    [Pg.134]    [Pg.996]    [Pg.537]    [Pg.1493]    [Pg.181]    [Pg.537]    [Pg.134]    [Pg.996]   
See also in sourсe #XX -- [ Pg.1710 ]

See also in sourсe #XX -- [ Pg.976 , Pg.993 , Pg.996 ]

See also in sourсe #XX -- [ Pg.488 ]




SEARCH



Gitelman syndrome

© 2024 chempedia.info